isabelobrien, Author at European Medical Journal - Page 58 of 70

Talking to Ana Rita Ferreira

Ana Rita Ferreira, Region Europe Medical Director, Novartis, discusses cancer care, women in STEM and misinformation.

Talking to Lorena Kuri

Lorena Kuri, Director of Clinical Trial Diversity Strategy, BMS, discusses how to address underrepresentation in clinical trials.

Talking to Rodrigo Garcia

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

Talking to Sir Clive Woodward part 2

Sir Clive Woodward, Former England Rugby Coach, discusses the importance of teams having aligned values and the rules of teamship.

Talking to Sir Clive Woodward part 1

Sir Clive Woodward, Former England Rugby Coach, discusses the concept of ‘Lombardi Time’ and how winning teams should embrace it.

Talking to Florent Edouard

Florent Edouard, ‎Senior Vice President, Global Head of Commercial Excellence, Grünenthal Group, talks about AI in digital transformation.

To be or to belong?

Diversity and inclusion (D&I) has become a core focus for pharma, but how can it go one step further and cultivate a culture of belonging?

Brexit revisited: how has the life sciences fared?

After years of tough negotiations, the UK has left the European Union. GOLD explores how pharmaceutical innovation has been affected as the UK works to replace EU resources and make use of its new-found regulatory freedom

How to build a disease awareness campaign remotely

The disruptor that is COVID-19 has turned everything upside down, including disease awareness campaigns. GOLD catches up with pharma marketing experts to see how they have adapted to their circumstances.

Talking to Emily Pegg

Dr Emily Pegg, Head of Medical Affairs UK, Takeda Oncology, discusses how pharma’s relationship with HCPs is evolving.